Dr. Saumya Pandey (M.Sc. Biochemistry, Ph.D. Life Science), constantly endeavors to contribute meaningfully to the ever-expanding clinical research field with emphasis on high-quality ethical scientific research with adherence to core tenets of bioethics and scientific integrity. I have a competitive publication track of 52 first authorships including senior authorships (54 publications/cumulative IF=226.524) in leading international journals along with expert Peer-Reviewer Recognition awards in translational research. I have earned 56 academic credits from Graduate Schools of Biomedical Sciences, Schools of Medicine, University of Texas Medical Branch, Galveston, Texas, USA, and Creighton University, Omaha, Nebraska, the USA with evidence-based clinical/clinical research observerships at New York Presbyterian-Weill Cornell Medical and Cold Spring Harbor Laboratory, New York, USA; further, I gained my healthcare-business management/strategy certificates from Harvard and Wharton Business Schools, USA. My areas of clinical research interests span Molecular Medicine, Immunobiology of Human Diseases, Electrophysiology, Neurodegenerative Diseases, Allergic Airway Inflammation/Asthma, Cardiovascular Diseases: Atherosclerosis/Neointima-Hyperplasia/Restenosis, Oncology: HPV-mediated Cervical Cancer, Breast Cancer, Colorectal and Hepatocellular Carcinomas, Prostate Cancer and Glioblastoma, Oncofertility and Health Disparities/Epidemiology, Obstetrics-Gynecology, Gynecologic Endocrinology, Reproductive Medicine: Female/Male Infertility and Urology/Sexual Medicine. I have successfully presented my innovative biomedical and public health research at the prestigious Keystone Symposia, Silverthorne, Colorado, USA, and American Society of Reproductive Medicine, Washington D.C./Birmingham, Alabama, USA scientific sessions during the current Covid-19/Omicron global pandemic. I have previously served as Faculty-Research/Science-Technology at Amity University Uttar Pradesh, Lucknow, India, and recently completed my assignment as Head-Clinical Research at a reputed India-based Fertility Hospital; with my inherent interest in impactful clinical/scientific research, teaching, mentoring, publishing and reviewing, I strongly believe in target-driven pragmatic scientific goals for achieving highest level(s) of academic excellence and eventual enriching scientific publishing experience for elegantly disseminating innovative clinical medicine and scientific concepts on a global platform.

Dr. Saumya Pandey is a reputed expert in clinical/biomedical research with a special emphasis on pulmonology and respiratory medicine. In my expert opinion, immunotherapeutic targeting of complex biochemical/metabolic signaling networks in dissecting the cellular/molecular/genetic basis of pulmonary/respiratory disorders viz. allergic airway inflammation, airway hyper-responsiveness, asthma, rhinitis and chronic obstructive pulmonary disease in ethnically disparate population-subsets, in the current Covid-19/Omicron global pandemic era, offers fascinating avenues for the development of predictive biomarkers and design of pharmacological scaffolds and novel drugs in evidence-based risk-stratification and disease management.